Showing results (21-30 of 556) with videos related to

Sort By:
Pageof 56
Clinical Medicine Insights. Oncology|June 3, 2024
The Impact of Baseline Vitamin D Level in Patients Receiving Gefitinib-Directed Therapy for EGFR-Mutant Non-Small-Cell Lung CancerVanita Noronha, Manali Kolkur, R ArunKumar, et al.
The Lancet. Oncology|May 4, 2013
Has the time come for metronomics in low-income and middle-income countries?Nicolas André, Shripad Banavali, Yuliya Snihur, et al.
Indian Journal of Surgical Oncology|April 25, 2022
Systemic Therapy in Thyroid CancerAmit Kumar Agrawal, Vanita Noronha, Vijay Patil, et al.
Ecancermedicalscience|September 8, 2022
Leptomeningeal metastasis from non-small cell lung cancer- a <i>post-hoc</i> analysis from four randomised clinical trialsVijay Patil, Vanita Noronha, Dilip Harindran Vallathol, et al.
Ecancermedicalscience|January 16, 2025
Intrathecal pemetrexed in NSCLC patients with leptomeningeal metastasisVanita Noronha, Vijay Patil, Zoya Peelay, et al.
South Asian Journal of Cancer|April 18, 2017
Role of neoadjuvant chemotherapy in advanced carcinoma of the hypopharynx and larynxPoonam Joshi, Amit Joshi, Vanita Norohna, et al.
Oral Oncology|January 13, 2015
A prospective randomized phase II study comparing metronomic chemotherapy with chemotherapy (single agent cisplatin), in patients with metastatic, relapsed or inoperable squamous cell carcinoma of head and neckVijay Maruti Patil, Vanita Noronha, Amit Joshi, et al.
South Asian Journal of Cancer|February 7, 2018
EMERALD: Emergency visit audit of patients treated under medical oncology in a tertiary cancer center: Logical steps to decrease the burdenAmit Joshi, Vijay M Patil, Vanita Noronha, et al.
Oral Oncology|April 3, 2022
RMAC study: A randomized study for evaluation of metronomic adjuvant chemotherapy in recurrent head and neck cancers post salvage surgical resection in those who are ineligible for re-irradiationVijay Patil, Vanita Noronha, Amit Joshi, et al.
Ecancermedicalscience|February 23, 2023
Retrospective analysis: checkpoint inhibitor accessibility for thoracic and head and neck cancers and factors influencing it in a tertiary centre in IndiaVijay Patil, George Abraham, Madala Ravikrishna, et al.
Pageof 56